Meet Optellum at the ATS 2018 Congress


Join us at the American Thoracic Society 2018 Congress in San Diego, North America’s premier congress for pulmonary medicine, from May 20 till May 23.
- Meet us at Booth No 6 in the Clinical Trials section (AI & Lung Cancer)
Learn about NIHR IDEAL, the world’s first prospective multi-center trial of Lung Cancer Prediction AI, led by Oxford University Hospitals with the authors of NICE and British Thoracic Society guidelines. - Visit our Scientific Poster (Tuesday May 22, 9.15am-11.15am)
Board 114: “Deep Learning-based Risk Stratification of Patients with Suspicious Nodules”
- See our Oral Presentation on the main scientific programme (Wednesday May 23, 2pm-2.15pm)
Dr. Timor Kadir, Chief Scientific & Technology Officer, presents a talk “Solid and Part-solid Lung Nodule Classification Using Deep Learning on the National Lung Screening Trial Dataset”.
Recent posts

August 24, 2026 / News & Press, Partnerships
SimonMed Launches World’s First Seamlessly Integrated AI Lung Nodule Risk Assessment WorkflowSimonMed is creating the first fully automated AI-powered lung cancer risk assessment workflow deployed at enterprise scale, combining multiple FDA-cleared AI technologies into a...
Read more

August 13, 2026 / News & Press, Partnerships
Coreline Soft and Optellum announce intent to collaborate to advance AI...Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform
Read more

June 15, 2026 / News & Press, Partnerships
Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated...Optellum announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive innovations to reduce waiting...
Read more
Optellum is trusted by industry & academic leaders




































Certification





Redefining early intervention of lung disease
starting with one of the deadliest, lung cancer
Contact us